Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Seretide cleared for marketing in most E.U. countries

Jan. 15, 1999

Novel condensed pyridazines claimed by Takeda for allergic conditions

Jan. 13, 1999

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Anti-IL-5R monoclonal antibodies and antagonists in development by Tanox

Dec. 29, 1998

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Dec. 28, 1998

Japanese approval sought for Accolate

Dec. 23, 1998

PathoGenesis reports encouraging phase II results for TOBI in bronchiectasis

Dec. 23, 1998

Pharmacological profile of dual LTD4/TxA2 receptor antagonist YM-158

Dec. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...